Seoul, South Korea

Dong Ho Kim

USPTO Granted Patents = 58 

 

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 85(Granted Patents)


Inventors with similar research interests:


Location History:

  • Daegu, KR (1999)
  • Suwon, KR (2000)
  • Gyeoggi-do, KR (2012)
  • Gyeonggi-do, KR (2013 - 2014)
  • Daejeon, KR (2012 - 2015)
  • Seongnam-si, KR (2015 - 2017)
  • Guri-si, KR (2016 - 2018)
  • Yongin-si, KR (2019 - 2021)
  • Seoul, KR (1999 - 2024)
  • Hwaseong-si, KR (2021 - 2024)

Company Filing History:

goldMedal14 out of 131,214 
 
Samsung Electronics Co., Ltd.
 patents
silverMedal8 out of 11,277 
 
Electronics and Telecommunications Research Institute
 patents
bronzeMedal7 out of 7 
 
Fdn. for Res.&bus., Seoul Nat. Univ. of Sci.&tech.
 patents
46 out of 26,887 
 
Samsung Display Co., Ltd.
 patents
55 out of 1,557 
 
Seoul National University
 patents
64 out of 49,601 
 
Lg Electronics Inc.
 patents
74 out of 146 
 
Hanmi Pharm. Co., Ltd.
 patents
84 out of 13 
 
Nunaps Inc.
 patents
91 out of 2 
 
Korea Mobile Telecommunications Corp.
 patents
101 out of 2,626 
 
Hyundai Mobis Co., Ltd.
 patents
111 out of 2,164 
 
Korea Institute of Science and Technology
 patents
121 out of 5 
 
Dong Yang Ink Co., Ltd.
 patents
131 out of 6 
 
Ceracomp Co., Ltd.
 patents
141 out of 76 
 
The Asan Foundation
 patents
151 out of 81 
 
University of Ulsan Foundation for Industry Cooperation
 patents
161 out of 29 
 
Crucialtec Co.ltd
 patents
171 out of 3 
 
Canvasbio Co., Ltd.
 patents
181 out of 1 
 
Woo Shin Emc Co., Ltd.
 patent
191 out of 94 
 
Humax Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...
Loading Chart...
58 patents (USPTO):

Dong Jin Kim is a renowned inventor and patent holder hailing from Seoul, South Korea. With a total of 635 patents to his name, his contributions to the field of innovation and invention are unmatched. Mr. Kim's latest patents include an alpha-aminoamide derivative compound and a passenger hand-luggage checking system and method for airports.

The alpha-aminoamide derivative compound has potential therapeutic applications. It acts as a reversible inhibitor of MAO-B, a common target for many drugs used in the treatment of various neurological and psychiatric disorders. Unlike existing drugs that use irreversible inhibitors, this compound can alleviate or eliminate the side effects of existing drugs acting via a covalent bond with MAO-B. This novel compound is superior in stability and efficacy compared to other reversible inhibitors, providing significant benefits for the treatment of neurological and psychiatric disorders.

The second patent secured by Mr. Kim is an innovative passenger hand-luggage checking system and method for airports. The system includes a platform to load a passenger hand luggage, a weight and size measurer to determine the weight and size of the luggage and an allowance-information provider to provide allowance information. The system also includes a regulation-based determiner that compares the weight and size of the passenger's luggage with the allowance allowed and provides check-out information about whether the luggage is within the allowed baggage limit. This inventive system enhances airport security measures and enables efficient processing at airport checkpoints.

Mr. Kim worked in renowned companies such as NeuroBiogen Co., Ltd. and CAS Corporation and collaborated with some notable coworkers such as Jae Hyun Lim and Hee Suk Pang. His groundbreaking patents impressively showcase his commitment to innovation and invention.

In conclusion, Dong Jin Kim has been a key figure in the field of innovation and patents, with numerous patents to his name. His newest patents address the latest challenges in the fields of medicine and security, highlighting his commitment to finding new solutions to old problems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…